Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review

被引:192
|
作者
Bicker, Joana [1 ,2 ]
Alves, Gilberto [2 ,3 ]
Fortuna, Ana [1 ,2 ]
Falcao, Amilcar [1 ,2 ]
机构
[1] Univ Coimbra, Pharmacol Lab, Coimbra, Portugal
[2] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal
[3] Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, P-6200506 Covilha, Portugal
关键词
Brain uptake; Cell culture; CNS drugs; Drug discovery and development; In vitro; In vivo; Neurovascular unit; PAMPA; Permeability screening; Targeted drug delivery; IN-VITRO MODEL; MICROVASCULAR ENDOTHELIAL-CELLS; POSITRON-EMISSION-TOMOGRAPHY; MEMBRANE-PERMEABILITY ASSAY; JUNCTION PROTEIN EXPRESSION; PEG-PLA NANOPARTICLES; P-GLYCOPROTEIN; COCULTURE MODEL; CELLULAR UPTAKE; FUNCTIONAL-CHARACTERIZATION;
D O I
10.1016/j.ejpb.2014.03.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the research and development of new drugs directed at the central nervous system, there is a considerable attrition rate caused by their hampered access to the brain by the blood-brain barrier. Throughout the years, several in vitro models have been developed in an attempt to mimic critical functionalities of the blood-brain barrier and reliably predict the permeability of drug candidates. However, the current challenge lies in developing a model that retains fundamental blood-brain barrier characteristics and simultaneously remains compatible with the high throughput demands of pharmaceutical industries. This review firstly describes the roles of all elements of the neurovascular unit and their influence on drug brain penetration. In vitro models, including non-cell based and cell-based models, and in vivo models are herein presented, with a particular emphasis on their methodological aspects. Lastly, their contribution to the improvement of brain drug delivery strategies and drug transport across the blood-brain barrier is also discussed. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:409 / 432
页数:24
相关论文
共 50 条
  • [1] CNS drug delivery: Opioid peptides and the blood-brain barrier
    Witt, KA
    Davis, TP
    AAPS JOURNAL, 2006, 8 (01): : E76 - E88
  • [2] CNS drug delivery: Opioid peptides and the blood-brain barrier
    Ken A. Witt
    Thomas P. Davis
    The AAPS Journal, 8
  • [3] Experimental Models of In Vitro Blood-Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective
    Chaulagain, Bivek
    Gothwal, Avinash
    Lamptey, Richard Nii Lante
    Trivedi, Riddhi
    Mahanta, Arun Kumar
    Layek, Buddhadev
    Singh, Jagdish
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [4] From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery
    Banks, William A.
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (04) : 275 - +
  • [5] Drug delivery and in vitro models of the blood-brain barrier
    Cucullo, L
    Aumayr, B
    Rapp, E
    Janigro, D
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (01) : 89 - 99
  • [6] Nanoscale drug delivery systems and the blood-brain barrier
    Alyautdin, Renad
    Khalin, Igor
    Nafeeza, Mohd Ismail
    Haron, Muhammad Huzaimi
    Kuznetsov, Dmitry
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 795 - 811
  • [7] Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
    Gabriel A Silva
    BMC Neuroscience, 9
  • [8] Blood-brain barrier structure and function and the challenges for CNS drug delivery
    Abbott, N. Joan
    JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) : 437 - 449
  • [9] Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
    Silva, Gabriel A.
    BMC NEUROSCIENCE, 2008, 9 (Suppl 3)
  • [10] Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
    Upadhyay, Ravi Kant
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014